NAGOYA, Japan--(BUSINESS WIRE)--Nagoya Anesthesia Clinic (https://nagoyamasui.com/), located in Nagoya City, Aichi Prefecture, Japan, has commenced inbound medical treatment for treatment-resistant...
Specifically aimed at autistic children in Pathlight and mainstream primary schools SINGAPORE - Media OutReach - 24 Oct 2023 -...
SEOUL, South Korea--(BUSINESS WIRE)--Korean Electronics Show, Seoul: Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce its...
Spackman Media Group artist Wi Ha-jun will headline a new romance K-drama, GRADUATION, directed by Ahn Pan-seok, who previously collaborated...
The enterprise work management leader’s newest regional deployment will provide customers the ability to host their data onshore in Australia,...
BANGKOK--(BUSINESS WIRE)--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to...
DENVER--(BUSINESS WIRE)--Gold Resource Corporation (NYSE American: GORO) (the “Companyâ€) will host a conference call Friday, November 3, 2023 at 10:00...
OrionVM’s MicroPoP Technology Enables Leading Australian Data Centre to Uniquely Underpin Cloud Workloads, Including Enterprise Cloud, AI and Storage Solutions...
Westwater Resources Offers Domestic Alternatives CENTENNIAL, Colo.--(BUSINESS WIRE)--Westwater Resources, Inc. (NYSE: American: WWR), an energy technology and battery-grade natural graphite...
DALLAS--(BUSINESS WIRE)--Nanban Ventures LLC (“Nanban Venturesâ€), a Dallas-based venture capital firm investing in startups and other private companies that are...
BEIJING--(BUSINESS WIRE)--Avistone Biotechnology Co., Ltd. (“Avistone†or “the Companyâ€), a clinical-stage biotechnology company focused on precision oncology therapeutics, announced preliminary...
Daiichi Sankyo and AstraZeneca’s ENHERTU showed a median progression-free survival of 6.9 months and median overall survival of 13.4 months...
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced the risk of disease progression or death by 25% in overall population and...
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan reduced the risk of disease progression or death by 37%, providing a 2-month median...
Month-long campaign delivers more than $100,000 to nonprofit partners, with record employee participation BOSTON--(BUSINESS WIRE)--athenahealth, Inc., a leading provider of...
